University of California, San Francisco: Carcinoma, Non-Small-Cell Lung trials
The registry lists 10 Carcinoma, Non-Small-Cell Lung studies with University of California, San Francisco as lead sponsor. 1 are open to participants now and 3 have results posted.
Phase 1 3Phase 2 5No phase 2(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Biomarkers for Risk Stratification in Lung CancerRecruitingNCT03774758
- National Comprehensive Cancer Network (NCCN) Decision Support Tool for Patients With NSCLCCompletedNCT03982459Not applicableResults posted
- Osimertinib in Treating Participants With Stage I-IIIA EGFR-mutant Non-small Cell Lung Cancer Before SurgeryActive, not recruitingNCT03433469Phase 2Results posted
- Trametinib in Patients With Advanced Neurofibromatosis Type 1 (NF1)-Mutant Non-small Cell Lung CancerTerminatedNCT03232892Phase 2Results posted
- Pembrolizumab With or Without Chemotherapy Before Surgery in Treating Patients With Stage I-IIIA Non-Small Cell Lung CancerWithdrawnNCT04061590Phase 2
- Brigatinib and Binimetinib in Treating Patients With Stage IIIB-IV ALK or ROS1-Rearranged Non-small Cell Lung CancerTerminatedNCT04005144Phase 1
- Ceritinib + Trametinib in Patients With Advanced ALK-Positive Non-Small Cell Lung Cancer (NSCLC)TerminatedNCT03087448Phase 1
- Stereotactic Radiosurgery and Erlotinib in Treating Patients With Non-Small Cell Lung Cancer and Brain MetastasesWithdrawnNCT00738335Phase 1
- Docetaxel, Carboplatin, and Bevacizumab in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Can Be Removed By SurgeryTerminatedNCT00293332Phase 2
- Combination Chemotherapy in Treating Patients With Metastatic Ovarian Cancer or Non-small Cell Lung CancerCompletedNCT00003072Phase 2